VIELA BIO, INC. Deferred Tax Assets, in Process Research and Development

VIELA BIO, INC. Deferred Tax Assets, in Process Research and Development

VIELA BIO, INC. had Deferred Tax Assets, in Process Research and Development of $21.64 million as of 2020-12-31, per its 10-K filed 2021-03-01.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2021-03-01

• 2020-12-31: Deferred Tax Assets, in Process Research and Development $21.64M.
• 2019-12-31: Deferred Tax Assets, in Process Research and Development $13.21M.
• 2018-12-31: Deferred Tax Assets, in Process Research and Development $4.74M.